In 2014, a virus called crAssphage that infects bacteria was discovered as part of the body’s intestinal environment. Now, a new study has investigated the origin and evolution of this virus, which may have coevolved with human lineage.
In 2014, a virus called crAssphage that infects bacteria was discovered as part of the body’s intestinal environment. Now, a new study has investigated the origin and evolution of this virus, which may have coevolved with human lineage.
Published in Nature Microbiology, a recent study shows that the virus was found in the sewage of more than one-third of the world’s countries. Additionally, the makeup of the virus can vary depending on in which country and city someone resides.
“The virus is both highly abundant in the human gut and represents an entirely new viral family. With this study, we were able to expand our understanding of the diversity and evolutionary history of the human microbiome globally,” said Kyle Bibby, co-author of the study and associate professor and Wanzek Collegiate Chair in the Department of Civil and Environmental Engineering and Earth Sciences. “Our team at Notre Dame has been evaluating the potential uses of this newly identified virus and is developing it as an alternative to E. coli or other fecal indicator bacteria that are not specific to humans, as an indicator of fecal pollution.”
The research was completed through a global collaboration of more than 115 scientists from 65 countries, allowing for the collection of a significant amount of sequencing data. This information was sampled from a variety of volunteers and from sewage samplings around the world. Genetic material data were also collected from primates as well as three pre-Columbian Andean mummies and a Tyrollean glacier mummy, which had 5,300-year-old intestinal content.
“We are in debt to all the amazing colleagues around the world who helped us explore the global diversity of this unique virus,” said Robert Edwards, project lead and professor of computer science and biology from San Diego State University. “This is truly a world first in the global scope and nature of the project.” Bibby’s research on the virus was funded by the National Science Foundation.
Bibby is an affiliated member of Advanced Diagnostics and Therapeutics, the Eck Institute for Global Health and the Environmental Change Initiative at Notre Dame.
Source: University of Notre Dame
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.